超敏性

Therapeutic mAbs has developed from reshaping antibody and humanized antibody to fully human antibody in order to lower supersensitivity resulting from mouse antibody.

为了降低鼠源抗的超敏反应,治疗性单克隆抗已由改型抗,人源化抗展到全人抗。